Day One Biopharmaceuticals Inc Cash Flow Reinvestment Rate
Day One Biopharmaceuticals Inc cash flow reinvestment rate. Day One Biopharmaceuticals Inc (DAWN) has a Cash Flow Reinvestment Rate of 2.43x as of September 2024, reinvesting $123.42 Million (capex $55.72 Million plus investments $-67.70 Million) from operating cash flow of $50.75 Million. See how financially flexible is Day One Biopharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Day One Biopharmaceuticals Inc Cash Flow Reinvestment Rate by Year (None–None)
Day One Biopharmaceuticals Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Day One Biopharmaceuticals Inc. For the full cash flow conversion analysis, see Day One Biopharmaceuticals Inc cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|